Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma

Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma

Genping Huang,1,* Ruizhe Chen,1,* Nanjia Lu,1 Qin Chen,2 Weiguo Lv,1,3 Baohua Li1,3 1Department of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 2Department of Pathology, Women’s Hospital,...

Full description

Bibliographic Details
Main Authors: Huang G, Chen R, Lu N, Chen Q, Lv W, Li B
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:OncoTargets and Therapy
Subjects:
the early-stage cervical adenocarcinoma
carcinoembryonic antigen
cancer antigen 125
prognosis
Online Access:https://www.dovepress.com/combined-evaluation-of-preoperative-serum-cea-and-ca125-as-an-independ-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/combined-evaluation-of-preoperative-serum-cea-and-ca125-as-an-independ-peer-reviewed-article-OTT

Similar Items